For investors and accelerators
See execution risk before it becomes milestone risk.
Translate technical, clinical, regulatory, quality, and manufacturing progress into a consistent view of execution readiness.
What you gain
Less ambiguity. Better decisions.
- A consistent stage model across devices and portfolio companies
- Eight-domain readiness summaries with visible evidence gaps
- Prioritized operating needs tied to provider capabilities
- A clearer basis for milestone planning and specialist diligence
Frame the product stage
Use common entry, activity, deliverable, risk, and exit criteria across the 12-stage realization roadmap.
Review readiness domains
Compare clinical, product, engineering, quality, regulatory, verification, manufacturing, and commercial maturity.
Identify evidence and execution gaps
Separate documented progress from assumptions and translate weaknesses into concrete operating priorities.
Connect teams to specialist support
Use verified capabilities and explained matching to find appropriate expertise without relying on an unstructured vendor search.
Decision support, not investment advice
Readiness results organize disclosed evidence and gaps. They do not validate product safety, predict regulatory outcomes, or replace specialist diligence.
Find your next move
Give portfolio teams a shared execution language.
Start with the 12-stage roadmap and use future readiness summaries to focus diligence and operating support.